Challenges of HTA Implementation the Case of Egypt

  • Slides: 16
Download presentation
Challenges of HTA Implementation: the Case of Egypt Gihan Elsisi, MSc, Ph. D Managing

Challenges of HTA Implementation: the Case of Egypt Gihan Elsisi, MSc, Ph. D Managing Director, HTA Office L. L. C Principal, Pharmacoeconomics Committee, Mo. H Founder & Former Head of Pharmacoeconomic Unit, Mo. H Lecturer, Faculty of Economics and Political Science, Cairo University Lecturer of Economic Modeling & Costing, Arab Academy for Science and Technology Lecturer, Faculty of Pharmacy, Heliopolis University Treasurer of ISPOR Egypt Chapter

Egyptian Pharmacoeconomic Unit Vision Provide scientific guidance of the value of drugs in delivering

Egyptian Pharmacoeconomic Unit Vision Provide scientific guidance of the value of drugs in delivering expected outcomes to decision makers, health professionals and the public. Mission Evaluate economic studies of both new and existing pharmaceutical products and medical devices. Conduct economic studies for products selected in Tender List, Essential Medicine List and Hospital Formulary. Provide education and training programs to build capacities.

3

3

4

4

5

5

Egyptian Guidelines 6

Egyptian Guidelines 6

7

7

8

8

Educational Activities 9

Educational Activities 9

10

10

Total 350000000 30000 84, 236, 124 Million 250000000 20000 150000000 10000 50000000 total Pre

Total 350000000 30000 84, 236, 124 Million 250000000 20000 150000000 10000 50000000 total Pre PEU Recommendations 347036787. 930322 Adopting PEU Recommendations 262800663. 040665 0 EGP

1200000 1000000 800000 600000 EGP 735303. 1691 EGP 400000 234950. 5095 EGP -1097. 813837

1200000 1000000 800000 600000 EGP 735303. 1691 EGP 400000 234950. 5095 EGP -1097. 813837 EGP Adopting PEU Recommendations cancer 350304. 407624562 multiple myeloma 115999. 313631584 orhhan diseases 35571. 2534347907 Pre PEU Recommendations 1085607. 57669001 350949. 823131897 34473. 439598043 200000 0

Challenges in HTA implementation No mandatory HTA legislations that fosters the implementation of cost-effectiveness

Challenges in HTA implementation No mandatory HTA legislations that fosters the implementation of cost-effectiveness studies. No localized clinical data to improve the validity and the implementation of cost-effectiveness studies. Lack of building capacities to improve the studies excellence to assure competent evaluations Less funding for the pharmacoeconomic unit to access international databases and cooperate with reputable firms specialized in this discipline.

Challenges in HTA implementation 1. No clear vision and strategies towards health care synchronization.

Challenges in HTA implementation 1. No clear vision and strategies towards health care synchronization. 2. No health care information system with the aim of creating an epidemiology profile for Egypt along with detailed local clinical data.

The current plan Raising awareness campaigns to the high level decision makers. Training programs

The current plan Raising awareness campaigns to the high level decision makers. Training programs to all the public and private hospitals. conducting more health economic studies to allocate our resources. Working with the health insurance organization (HIO) to build the HTA department. 15

Thank you so much for paying attention For any queries, Please contact: Gihan

Thank you so much for paying attention For any queries, Please contact: Gihan Elsisi Gihan. elsisi@htaoffice. com 01227366018